Diagnostic evaluation of pancreatic carcinoma prompting treatment decisions;Pankreaskarzinom: Präzisierung der Diagnostik zur weiteren Therapieplanung

Chirurg

Volumn 74, Issue 3, 2003, Pages 171-182

  Welzel, T M ^a   Vick, C ^a   Reiser, M ^a   Goke B ^a  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

Author keywords

Computer tomography; Endosonography; ERCP; Magnetic resonance tomography; Molecular marker; Pancreatic cancer; Positron emission tomography; TNM classification; Tumor marker

Indexed keywords

GADOLINIUM CHELATE; TUMOR MARKER;

CANCER INHIBITION; CANCER RISK; CANCER SCREENING; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; COMPUTER ASSISTED TOMOGRAPHY; ENDOSCOPIC ECHOGRAPHY; ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY; HUMAN; METASTASIS; ONCOGENE; PANCREAS CANCER; POPULATION RISK; POSITRON EMISSION TOMOGRAPHY; PUBLICATION; REVIEW; SURVIVAL RATE; TUMOR SUPPRESSOR GENE; COMPARATIVE STUDY; COMPUTER ASSISTED EMISSION TOMOGRAPHY; DIFFERENTIAL DIAGNOSIS; ECHOGRAPHY; MORTALITY; NUCLEAR MAGNETIC RESONANCE IMAGING; PANCREAS TUMOR; PROGNOSIS; RADIOGRAPHY; RISK FACTOR; SCINTISCANNING; TIME;

CHOLANGIOPANCREATOGRAPHY, ENDOSCOPIC RETROGRADE; DIAGNOSIS, DIFFERENTIAL; ENDOSONOGRAPHY; HUMANS; MAGNETIC RESONANCE IMAGING; PANCREATIC NEOPLASMS; PROGNOSIS; RISK FACTORS; TIME FACTORS; TOMOGRAPHY, EMISSION-COMPUTED; TUMOR MARKERS, BIOLOGICAL;

EID: 0038620422     PISSN: 00094722     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00104-003-0626-6     Document Type: Review

References (51)

1. Adamek HE, Albert J, Breer H et al. (2000) Pancreatic cancer detection with magnetic resonance cholangiopancreatography and endoscopic retrograde cholangiopancreatography: a prospective controlled study. Lancet 356:190
2. Albrecht T, Hoffmann CW, Schmitz SA et al. (2001) Phase inversion sonography during the liver-specific late phase of contrast enhancement: improved detection of liver metastases. Am J Roentgenol 176:1191
3. American Society for Gastrointestinal Endoscopy (1999) The role of ERCP in diseases of the biliary tract and pancreas. Gastrointest Endosc 50:915
4. Angeli E, Venturini M, Vanzulli A et al. (1997) Color doppler imaging in the assessment of vascular involvement by pancreatic carcinoma. Am J Roentgenol 168:193
5. Ariyama J, Suyama M, Satoh K et al. (1998) Imaging of small pancreatic ductal adenocarcinoma. Pancreas 16:396
6. Bares R, Dohmen BM, Cremerius U et al. (1996) Results of positron emission tomography with fluorine-18 labeled fluorodeoxyglucose in differential diagnosis and staging of pancreatic carcinoma. Radiologe 36:435
7. Brandt KR, Charbrideau JW, Stephenss DH et al. (1993) CT and US guided biopsy of the pancreas. Radiology 187:99
8. Brugge WR, Lee MJ, Kelsey PB et al. (1996) The use of EUS to diagnose malignant portal venous system invasion by pancreatic tumors. Gastrointest Endosc 43:561
9. Delbeke D, Rose DM, Chapman WC et al. (1999) Optimal interpretation of FDG PET in the diagnosis, staging and management of pancreatic carcinoma. J Nucl Med 40:1784
10. Diehl SJ, Lehmann KJ, Sadick M, Lachmann R (1998) Pancreatic cancer: value of dual-phase helical CT in assessing respectability. Radiology 206:373
11. Diehl SJ, Lehmann KJ, Gaa J et al. (1999) Wertigkeit von Magnetresonanztomographie (MRT), Magnetresonanz-Cholangiopankreatikographie (MRCP) und endoskopischer retrograder Cholangiopankreatikographie (ERCP) bei der Diagnose von Pankreastumoren. Fortschr Röntgenstr 170:463
12. Durie P, Lerch MM, Lowenfels AB et al. (2002) Genetic disorders of the exocrine pancreas. Karger, Basel (Updated Reprint of Pancreatology 1; No. 5, 2001)
13. Ellis I, Lerch MM, Whitcomb DC for the Censensus Committees of the European Registry of Heriditary Pancreatic Diseases, the Midwest Multi-Center Pancreatic Study Group and the International Association of Pancreatology (2001) Genetic testing for heriditary pancreatitis: guidelines for indications, counselling, consent and privacy issues. Pancreatology 1:405
14. Fink C, Grenacher L, Hansmann HJ et al. (2001) Prospective study to compare high-resolution computed tomography and magnetic resonance imaging in the detection of pancreatic neoplasms: use of intravenous and oral MR contrast media. Röfo Fortschr Geb Röntgenstr Neuen Bildgeb Verfahr 173:724
15. Freeny PC, Marks WM, Ryan JA, Traverso LW (1988) Pancreatic ductal adenocarcinoma: diagnosis and staging with dynamic CT. Radiology 166:125
16. Freeny PC (2001) Pancreatic carcinoma: imaging update 2001. Digestive Diseases 19:37
17. Gress FG, Hawes RH, Savides TJ et al. (1999) Role of EUS in the preoperative staging of pancreatic cancer: a large single-center experience. Gastrointest Endosc 50:786
18. Hanbidge AE (2002) Cancer of the pancreas: the best image for early detection - CT, MRI, PET, or US? Can J Gastroenterol 16:101
19. Hänninen LE, Amthauer H, Hosten N et al. (2002) Prospective evaluation of pancreatic tumors: accuracy of MR imaging with MR cholangiopancreatography and MR angiography. Radiology 224:34
20. Helmberger T, Holzknecht N, Gauger J et al. (1996) MRT des Pankreas: Radiologisch-pathologische Korrelation. Radiologe 36:419
21. Hirooka Y, Goto H, Ito A et al. (2001) Recent advances in US diagnosis of pancreatic cancer. Hepatogastroenterology. 40:916
22. Holzknecht N, Gauger J, Helmberger T et al. (1996) Techniques and application of MR-pancreatography compared to endoscopic retrograde pancreatography. Radiologe 36:427
23. Horton KM, Fishman EK (2002) Multidetector CT angiography of pancreatic carcinoma: Part 1, Evaluation of arterial involvement. AJR Am J Roentgenol 178:827
24. Horton KM, Fishman EK (2002) Multidetector CT angiography of pancreatic carcinoma: Part 2, Evaluation of venous involvement. AJR Am J Roentgenol 178:833
25. Hunt GC, Faigel DO (2002) Assessment of EUS for diagnosing, staging and determining respectability of pancreatic cancer: a review. Gastrointest Endos 55:232
26. Imbriaco M, Megibow AJ, Camera L, Pace L (2002) Dual-phase versus single-phase helical CT to detect and assess resectability of pancreatic carcinoma. AJR Am J Roentgenol 178:1473
27. Karlson BM, Ekbom A, Lindgren, PG et al. (1999) Abdominal US for diagnosis of pancreatic tumor: a prospective cohort analysis. Radiology 213:107
28. Lamerz R (1999) Role of tumor markers, cytogenetics. Ann Oncol 10 [Suppl]:145
29. Loperfido S, Giampaolo A, Benedetti G et al. (1998) Major early complications from diagnostic and therapeutic ERCP: a prospective multicenter study. Gastrointest Endosc 48:1
30. Lynch HT, Brand RE, Deters CA et al. (2001) Heriditary pancreatic cancer. Pancreatology 1:466-471
31. Martin SP, Ulrich CD (2000) Pancreatic cancer surveillance in a high-risk cohort. Is it worth the cost? Med Clin North Am 84:739
32. Meining A, Dittler HJ, Wolf A et al. (2002) You get what you expect? A critical appraisal of imaging methodology in endosonografic cancer staging. Gut 50:599
33. National Institute of Health (2002) State-of-the-Science Conference Statement: Endoscopic Retrograde Cholangiopancreatography (ERCP) for diagnosis and therapy. www.nih.gov
34. Nino-Murcia M, Jeffrey RB Jr, Beaulieu CF et al. (2001) Multidetector CT of pancreas and bile duct system: value of curved planar reformations. AJR Am J Roentgenol 176:689
35. Reske S, Grillenberger KG, Glatting G et al. (1997) Overexpression of glucose transporter and increased F-18 FDG uptake in pancreatic carcinoma. J Nucl Med 38:1344
36. Rickes S, Unkrodt K, Ocran K et al. (2002) Fallbeispiele zur Erläuterung der Differenzialdiagnostik von häufigen Pankreastumoren mit der echosignalverstärkten Power-Dopplersonografie. Z Gastroenterol 40:235
37. Robinson PJA (2002) The role of MRI in pancreatic cancer. Eur Radiol 12:2697
38. Rösch T, Braig C, Gain T et al. (1992) Staging of pancreatic and ampullary carcinoma by endoscopic ultrasonografy. Gastroenterology 102:188
39. Rösch TR, Dittler HJ, Strobel K et al. (2000) Endoscopic ultrasound criteria for vascular invasion in staging of cancer of the pancreatic head of the pancreas: a blind reevaluation of videotapes. Gastrointest Endosc 52:469
40. Schima W, Függer R, Schober E et al. (2002) Diagnosis and staging of pancreatic cancer: comparison of mangafodipir trisodium-enhanced MR imaging and contrast-enhanced helical hydro-CT. AJR Am J Roentgenol 179:717
41. Smith AC, Dowsett JF, Russell RC et al. (1994) Randomised trial of endoscopic stenting versus surgical bypass in malignant low bile duct obstruction. Lancet 1994:1655
42. Steinberg W (1990) The clinical utility of the CA 19-9 tumor-associated antigen. Scand J Gastroenterology 85:350
43. Sternheim ET, Voigt J, Kaspar W, Dippold WG (2000) Das Pankreaskarzinom. Internist 41:848
44. Ueno N, Tomiyama T, Tano S et al. (1997) Color doppler ultrasonography in the diagnosis of portal vein invasion in patients with pancreatic cancer. J Ultrasound Med 16:825
45. Ulrich CD for the Censensus Committees of the European Registry of Heriditary Pancreatic Diseases, the Midwest Multi-Center Pancreatic Study Group and the International Association of Pancreatology (2001) Pancreatic cancer in heriditary pancreatitis: consensus guidelines for prevention, screening and treatment. Pancreatology 1:416
46. Dual-phase helical CT of pancreatic adenocarcinoma: assessment of resectability before surgery. AJR Am J Roentgenol 178:821
47. Vogl TJ, Luboldt W, Herzog C, Hammerstingl R (2002) Kontrastverstä rkte Mehrschicht-Computertomographie in der Detektion und Evaluation abdomineller Neoplasien. Radiologe 42:646
48. Voss M, Hammel P, Molas G et al. (2000) Value of ultrasound guided fine needle aspiration in the diagnosis of solid pancreatic masses. Gut 46:244
49. Wagner M, Dikoupulos N, Kulli C et al. (1999) Standard surgical treatment in pancreatic cancer. Ann Oncol 10 [Suppl]:247
50. Williams DB, Sahai AV, Aabakken, SL et al. (1999) Endoscopic ultrasound guides fine needle aspiration bioply: a large single center experience. Gut 44:720
51. Zech CJ, Helmberger T, Wichmann MW et al. (2002) Large core biopsy of the pancreas under CT fluoroscopy control: results and complications. J Comput Assist Tomogr 26:743